| ²é¿´: 2916 | »Ø¸´: 60 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
·ÖÏí¿¹Ö×ÁöÒ©ÎïºÃÊéÒ»±¾<Cancer Drug Design and Discovery>2008¡¾ËÑËØÎÞÖØ¸´¡¿
|
||
|
Stephen Neidle is Professor of Chemical Biology, CRUK Professorial Fellow, and Director of the Centre for Cancer Medicines at the School of Pharmacy, University of London, where he directs a group working on the structure-based design and medicinal chemistry of novel agents targeting telomerase and other cancer-related genes. His work has been recognized by the Medicinal Chemistry and Interdisciplinary Awards of the Royal Society of Chemistry, and the Aventis Award of the French Societ¨¦ de Chimie Th¨¦rapeutique. ¸Õ´ÓSDÉÏÏÂÔØµÄ£¬Óë´ó¼Ò·ÖÏí http://d.namipan.com/d/77342c456aeb1ebcf10b6aff32d0799dffeb91ffa7517f00 |
» ²ÂÄãϲ»¶
085600 ²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
»¯Ñ§¹¤³Ì085602 305·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸£ºÎ÷±±´óѧ£¬Ó¢Ò»ÊýÒ»408-284·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
52Â¥2009-12-01 21:38:42
8Â¥2009-08-16 09:15:24
11Â¥2009-08-16 10:13:14
14Â¥2009-08-16 14:05:13
¼òµ¥»Ø¸´
tjegg3Â¥
2009-08-15 20:14
»Ø¸´

















»Ø¸´´ËÂ¥